BREAKTHROUGH: All 18 hospitalized individuals at the Ziv Medical Center in Safed that were administered Amor-18 from Amorphical, recovered in a phase II trial and were shortly discharged.
By ROSSELLA TERCATIN
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
The trial was conducted at the Ziv Medical Center in Safed and led by the directors of the coronavirus department, Dr. Continue Reading »
Although the 30th patient also fully recovered later on, 29 out of 30 moderate-to-severe COVID-19 patients recovered from the disease and were released within 3 to 5 days after using a new treatment developed by Tel Aviv’s Sourasky Medical Center.
By MAAYAN JAFFE-HOFFMAN
Twenty-nine out of 30 moderate-to-severe COVID-19 patients who were administered a treatment developed by Tel Aviv’s Sourasky Medical Center (Ichilov Hospital) as part of a Phase I trial recovered from the disease and were released within three to five days, the hospital said Friday.
The 30th patient also recovered but it took longer.
Prof. Nadir Arber – Photo: Ichilov Hospital
The patients were given Prof. Continue Reading »
This study conducted at the Tel Aviv University has proven that 99.9% of the COVID-19 virus can be killed cheaply and within 30 seconds by using UV light-emitting diodes (UV-LEDs) at specific frequencies.
By MAAYAN JAFFE-HOFFMAN
Ultraviolet radiation is a common method of killing bacteria and viruses. Now, researchers from Tel Aviv University have proven that the novel coronavirus, SARS-CoV-2, can be killed efficiently, quickly and cheaply using ultraviolet (UV) light-emitting diodes (UV-LEDs) at specific frequencies.
“We discovered that it is quite simple to kill the coronavirus using LED bulbs that radiate ultraviolet light,” said Prof. Hadas Mamane, head of the Environmental Engineering Program at Tel Aviv University’s School of Mechanical Engineering, who led the study with Prof. Continue Reading »
Gulf State journalists mock Abbas following the Palestinian autocrat’s tantrum that severed ties with Israel, ending the ability of Gazans & Palestinians to be treated in Israeli hospitals, but granted exception for fellow kleptocrat, PLO chief Saeb Erekat.
By Baruch Yadid/TPS
Saeb Erekat, secretary-general of the PLO and chief Palestinian Authority negotiator, is currently hospitalized in serious condition at Jerusalem’s Hadassah Ein Kerem Hospital. Erekat had a lung transfer a year ago, and has contracted COVID-19.
There is a great embarrassment in the PA following Erekat’s hospitalization because it is a step that requires civilian and security coordination with Israel and exposes the discrimination of senior PA officials over its residents, who are banned from seeking medical treatment in Israel. Continue Reading »
The first implants of the Israeli startup CorNeat Vision’s synthetic cornea, which bio-integrates with the host’s eye, has received approval to conduct clinical trials on patients at Beilinson Hospital in central Israel.
By ILH Staff
The Israeli startup CorNeat Vision has received approval to conduct clinical trials of a synthetic cornea that bio-integrates with the human eye.
The Health Ministry-approved trial of the CorNeat KPro will be run at Beilinson Hospital in Petach Tikva on 10 patients suffering from corneal blindness who are either not candidates for or have experienced one or more failed cornea transplants, the company announced last week. Continue Reading »
Israeli Defense Ministry spokesperson reported that researchers at the Israel Institute for Biological Research identified two antiviral drugs as an effective treatment for COVID-19.
– One, an FDA-approved drug and the second, already in the advanced stages of the approval process.
By Arutz Sheva Staff
As part of the wide-ranging efforts of the Israel Institute for Biological Research to identify antiviral drugs for COVID-19, scientists have tested an analogue of the FDA-approved Cerdelga drug, and an analogue of a second drug that is currently in advanced stages of the approval process, an Israeli Defense Ministry spokesperson said Tuesday.
Treatment of a new disease such as COVID-19 using an existing, approved drug may serve as an effective short-term solution considering that one of the major challenges in addressing such a pandemic is the length of time it takes for both the research and approval phases of new drugs. Continue Reading »
Prof. Dror Harats, the head of research at Sheba Medical Center at Tel Hashomer says the union with the U.S. National Institute of Health will expedite efforts that “lead to a vaccine and saving lives.”
By Maytal Yasur Beit-Or
Israel’s Chaim Sheba Medical Center at Tel Hashomer will be teaming up with the US National Institute of Health (NIH) to find a vaccine for coronavirus.
According to the plan, Sheba will send the NIH’s Vaccine Research Center samples of blood, plasma, and the virus itself taken from corona patients examined in Israel, as well as all relevant information the hospital collects during the clinical studies it runs itself and in conjunction with international pharmaceutical companies. Continue Reading »
According to a statement by Israel’s Defense Ministry, the Israel Institute for Biological Research “is the first institution to achieve a scientific breakthrough that meets all three” of the parameters needed.
– Collaborating with the town of Yeroham, a planned vaccine production facility will ensure Israeli self-sufficiency for both regular routine vaccinations and in cases of a pandemic.
By MAAYAN JAFFE-HOFFMAN, ANNA AHRONHEIM, IDAN ZONSHINE
The Israel Institute for Biological Research (IIBR) has completed a groundbreaking scientific development, identifying an antibody that neutralizes the coronavirus, SARS-CoV-2, according to a statement by the Defense Ministry.
“I am proud of the Biological Institute staff, who have made a major breakthrough,” said Defense Minister Naftali Bennett on Monday after visiting the Ness Ziona-based lab. Continue Reading »
Mixing Apples & Oranges: An Israeli left-wing campaign video focuses on the unquestioned trust by all of Israel with their Arab health officials, in virtually all levels in every hospital throughout Israel, but conveniently ignores the real issues at hand about their political leaders, some of whom have applauded, even assisted terrorists.
By Israel Today Staff
A viral video campaign is asking Israeli Jews to trust their Arab countrymen in politics the same as they trust them in health care.
The “Partners in Fate; Partners in Government” video has been viewed nearly 2 million times in Hebrew. The 55-second clip features a series of Israeli Arab doctors and nurses, noting that they, alongside their Jewish colleagues, have won the praise of the entire nation during the battle against the coronavirus. Continue Reading »
The Israeli masks, with sizes to fit adults, kids or men with full beards, are made of high-density cotton which can be disinfected in a 60° C laundry cycle for almost unlimited reuse, as global demand has made single-use masks scarce, or too overpriced.
Israel is heading off shortages of disposable surgical masks during the coronavirus crisis by mass-producing washable versions sized to fit everyone from children to bearded men who shun shaving due to their religion.
As part of stepped-up precautions against the virus, Prime Minister Benjamin Netanyahu’s government on Sunday made it compulsory for Israelis to cover their mouths and noses while in public. Continue Reading »
Forbes published its comprehensive study ranking how 60 countries are dealing with the coronavirus, determining Israel is the safest country in the world to be in fighting against the pandemic.
By Arutz Sheva Staff
A study published in Forbes Magazine presents a comprehensive analysis examining the steps taken in various countries around the world as part of the fight against the spread of the Corona virus.
In the study, 60 countries are ranked according to different factors, including safety, risk level, treatment efficacy, and government support for people affected by the economic impact of the virus.
Continue Reading »
A police officer mans a checkpoint at the entrance to Bnei Brak.-
According to preliminary data provided by the Haifa-based company, not only have all six of the critically ill coronavirus patients that were treated survived, but four of them showed improvement in respiratory parameters.
By MAAYAN JAFFE-HOFFMAN
Six critically ill coronavirus patients in Israel who are considered high-risk for mortality have been treated with Pluristem’s placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.
The patients were treated at three different Israeli medical centers for one week under the country’s compassionate use program and were suffering from acute respiratory failure and inflammatory complications associated with COVID-19. Continue Reading »
WATCH: Israel’s Kan TV 11NEWS broadcast touching scenes showing just how much Israelis, throughout the Jewish State, appreciates its doctors, nurses and medics by going out onto their balconies to applaud them.
By Israel Today Staff
Israel’s Kan TV 11NEWS showed how Israelis across the country answered a call to publicly show appreciation for the heroic efforts of the nation’s medical personnel in combatting the spread of COVID-19, known commonly as the coronavirus.
In nearly every town and village, people confined to their homes by new government regulations went out to their balconies and broke into a two-minute round of applause. Continue Reading »
The Israeli Drugmaker, Teva Pharmaceutical rushes to send its Malaria drug to Covid-19 patients in U.S. hospitals following encouraging results from China and France. Teva said 6 million tablets will be delivered to U.S. hospitals by March 31, and more than 10 million in a month.
By Riley Griffin
Teva Pharmaceutical Industries Ltd. said it plans to donate more than 10 million tablets of hydroxychloroquine sulfate, a malaria drug touted by President Donald Trump as a potential treatment for the coronavirus, to help U.S. hospitals meet a potential surge in demand.
The Israeli company is one of the world’s largest makers of hydroxychloroquine, a less-toxic version of chloroquine, which is used in malaria, rheumatoid arthritis and lupus. Continue Reading »